Zobrazeno 1 - 10
of 733
pro vyhledávání: '"fibrosis-4"'
Autor:
Fuad A. Abdu, Redhwan M. Mareai, Lanqing Xiang, Jassur. Galip, Abdul‐Quddus Mohammed, Wen Zhang, Lu Liu, Chunyue Wang, Ayman A. Mohammed, Guoqing Yin, Xian Lv, Yawei Xu, Wenliang Che
Publikováno v:
ESC Heart Failure, Vol 11, Iss 6, Pp 3934-3945 (2024)
Abstract Aims The fibrosis‐4 index (FIB‐4) is a non‐invasive tool to assess fibrosis risk in chronic liver disease. We aimed to explore the relationship between the FIB‐4 index and long‐term major adverse cardiovascular events (MACE) in HCM
Externí odkaz:
https://doaj.org/article/3b5ae21adfc34fb8ac1ab305eca4750d
Autor:
Poppy Diah Palupi, Chun-Yu Wei, Wan-Hsuan Chou, Min-Rou Lin, Yu-Jui Yvonne Wan, Wei-Chiao Chang
Publikováno v:
Cell & Bioscience, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Background The fibrosis-4 (FIB-4) index is a non-invasive method to assess the severity of liver fibrosis. The development of liver fibrosis is influenced by genetic predisposition and dietary factors. However, the modulating effect of dieta
Externí odkaz:
https://doaj.org/article/27a9fbe0da1148b8adc10d52719994b4
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background The impact of liver fibrosis on the clinical outcomes of patients with sepsis-induced coagulopathy (SIC) is not well understood. This study aimed to evaluate the association between liver fibrosis scores and in-hospital mortality
Externí odkaz:
https://doaj.org/article/e9516787aa804ca7b5cb19bd6b65bbbf
Prognostic Value of Fibrosis-4 in Acute Ischemic Stroke Patients Undergoing Intravenous Thrombolysis
Publikováno v:
Clinical Interventions in Aging, Vol Volume 19, Pp 1663-1674 (2024)
Hong-Jing Zhu,1,* Sheng-Yu Zhou,1,* Yang Qu,1 Ying-Ying Sun,1 Ke-Jia Zhang,1 Shu-Yan Pang,1 Yi Yang,1 Zhen-Ni Guo1,2 1Stroke Center, Department of Neurology, The First Hospital of Jilin University, Chang Chun, People’s Republic of China; 2N
Externí odkaz:
https://doaj.org/article/ac4747bd50994875bdc4ee15fa38cb7c
Autor:
Stefano Del Prato, Zhuoru Li, Chinthanie Ramasundarahettige, Kelley R. H. Branch, Carolyn S. P. Lam, Renato D. Lopes, Richard Pratley, Julio Rosenstock, Naveed Sattar, Hertzel C. Gerstein
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-7 (2024)
Abstract Aims To estimate the incidence of major adverse cardiovascular events (MACE), expanded MACE, and MACE or Death across Fibrosis- 4 score (FIB-4) categories in people with type 2 diabetes and to determine whether efpeglenatide’s effect varie
Externí odkaz:
https://doaj.org/article/5aca8709d53749818d134c8d95f3c546
Publikováno v:
Infection and Drug Resistance, Vol Volume 17, Pp 3037-3045 (2024)
Peng Zhou,1 Lingling Ye,2 Shixiao Li3 1Department of Pharmacy, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People’s Republic of China; 2Department of Science and Education, Taizhou Hospital of Zhejiang
Externí odkaz:
https://doaj.org/article/6be10c336c5740be9c4ce42337ed6c49
Autor:
Shinya Yamada, Takashi Kaneshiro, Minoru Nodera, Kazuaki Amami, Takeshi Nehashi, Masayoshi Oikawa, Takayoshi Yamaki, Kazuhiko Nakazato, Takafumi Ishida, Yasuchika Takeishi
Publikováno v:
Journal of Arrhythmia, Vol 40, Iss 3, Pp 585-593 (2024)
Abstract Background The relationship between liver fibrosis and left atrial (LA) remodeling in atrial fibrillation (AF) remains uncertain. We examined the associations between the fibrosis‐4 (FIB4) index, an indicator of liver fibrosis, and both LA
Externí odkaz:
https://doaj.org/article/5a2ecc986a7b41b291f40efbbc86dc86
Publikováno v:
Journal of Inflammation Research, Vol Volume 17, Pp 3967-3982 (2024)
Jia Shi,1,2,* Meng-Jiao Shao,3,* Miao Yu,1,2 Bao-Peng Tang1,2 1Cardiac Pacing and Physiological Department, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, People’s Republic of China; 2Xinjiang Key Laboratory
Externí odkaz:
https://doaj.org/article/6fa31193eefa437c9f5a414605b06dfa
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract The objective of our work was to evaluate the screening of hepatic fibrosis in primary care using the FIB-4 score, automatically calculated. When the FIB-4 was ≥ 1.3, it was defined as positive, and ELF Test was performed. FIB-4 positivity
Externí odkaz:
https://doaj.org/article/efa3e4ba993d4a4a81d7e3b9299e99ef
Autor:
Joost Boeckmans, Maurice Michel, Alexander Gieswinkel, Oliver Tüscher, Stavros V. Konstantinides, Jochem König, Thomas Münzel, Karl J. Lackner, Jasmin Ghaemi Kerahrodi, Alexander K. Schuster, Philipp S. Wild, Peter R. Galle, Jörn M. Schattenberg
Publikováno v:
JHEP Reports, Vol 6, Iss 10, Pp 101171- (2024)
Background & Aims: Elevated liver stiffness has been associated with atrial fibrillation (AFib) in the general population. The mechanism underlying this association is unclear. Methods: Participants were recruited from the general population and pros
Externí odkaz:
https://doaj.org/article/dbb6653caaf54e8bbf49c5a6cce8895e